Table 2.
Measures of glycaemic and blood pressure control at the baseline and at 4 and 8 years after the start of intervention
Variable | Baseline | 4 years after start of intervention | 8 years after start of intervention |
---|---|---|---|
BMI (kg/m2) | 23.0 ± 2.9 | 23.0 ± 3.0 | 23.0 ± 3.1 |
SBP (mmHg) | 132.4 ± 15.8 | 132.5 ± 15.4 | 132.5 ± 15.9 |
DBP (mmHg) | 76.6 ± 9.5 | 75.9 ± 9.1 | 74.0 ± 10.0 |
Fasting plasma glucose (mmol/l) | 8.9 ± 2.4 | 8.9 ± 2.6 | 8.6 ± 2.5 |
HbA1c (%) | 7.8 ± 1.3 | 7.7 ± 1.2 | 7.7 ± 2.0 |
Hypoglycaemic agent (%) | |||
Any use | 84.4 | 89.3 | 86.6 |
Insulin | 20.7 | 30.1 | 41.9 |
Sulfonylurea | 62.3 | 63.3 | 59.7 |
Alpha-glucosidase inhibitor | 25.9 | 29.9 | 28.8 |
Biguanide | 7.5 | 16.1 | 32.8 |
Insulin sensitiser | 1.2 | 8.0 | 9.1 |
Antihypertensive agent (%) | |||
Any use | 28.2 | 33.3 | 42.0 |
ACE inhibitor/ARB | 12.3 | 16.6 | 28.4 |
Calcium-channel blocker | 20.7 | 24.4 | 27.2 |
Diuretic | 1.2 | 1.1 | 2.9 |
Other | 6.0 | 7.1 | 8.6 |
Statin (%) | 20.5 | 23.7 | 31.1 |
Each value is expressed as mean ± SD or percentage
DBP, diastolic blood pressure